Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
XPH
40
HOLDINGS
38%
ALSO IN FTXH
FTXH
49
HOLDINGS
31%
ALSO IN XPH
SECTOR DRIFT (XPH minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 4.0% | 8.3% | 4.0% |
|
VIATRIS, INC. | 3.9% | 4.1% | 3.9% |
|
MERCK & CO. INC. | 3.6% | 6.9% | 3.6% |
|
PFIZER INC | 3.6% | 7.3% | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.3% | 6.1% | 3.3% |
XPH Overweight Relative to FTXH
|
TARSUS PHARMACEUTICALS, INC. | 4.2% |
|
ROYALTY PHARMA PLC CLASS A | 4.0% |
|
AXSOME THERAPEUTICS, INC. | 3.0% |
|
CORCEPT THERAPEUTICS INC | 3.0% |
|
BIOSANTE PHARMACEUTICALS INC | 2.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.8% |
|
PACIRA PHARMACEUTICALS INC | 2.6% |
|
SUPERNUS PHARMACEUTICALS INC | 2.5% |
|
OCULAR THERAPEUTIX INC | 2.5% |
|
LIGAND PHARMACEUTICALS-CL B | 2.3% |
XPH Underweight Relative to FTXH
|
ABBVIE INC | -7.5% |
|
JOHNSON & JOHNSON | -4.3% |
|
GILEAD SCIENCES INC | -4.1% |
|
PFIZER INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
AMGEN INC | -3.7% |
|
BIOGEN IDEC INC | -3.7% |
|
MERCK & CO. INC. | -3.3% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |